article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

The AI revolution has been and will continue to redefine the pharmaceutical industry in 2024, promising transformative outcomes for patients. Jason Rose, CEO at Adhere Health 2024 will spark transformational change across the pharmaceutical industry. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

How to Tackle Pharma’s 3 Biggest Compliance Risks Head-On with Verisys

Verisys

Throughout that process, he was still on our payroll, and we hadn’t been doing our due diligence to screen him.” These issues can cause reputational damage to the manufacturer if they aren’t monitoring their faculty. He was sentenced to life in prison, and the story received national attention.

article thumbnail

Terrorist (Litigation) Threats

Drug & Device Law

6, 2022) (legislative power to “deem” something as “consent” to personal jurisdiction in JASTA cannot so deem actions that could not otherwise support jurisdiction consistently with Due Process). And in a positively putrid opinion, an appellate court has just let them do it. See Atchley v. AstraZeneca UK Ltd. , 4th 204 (D.C. Happy New Year’s.